Market Overview:
Blood-banking equipment market size was valued at USD 16347 million in 2024 and is anticipated to reach USD 23786.3 million by 2032, at a CAGR of 4.8 % during the forecast period (2024-2032).
| REPORT ATTRIBUTE |
DETAILS |
| Historical Period |
2020-2023 |
| Base Year |
2024 |
| Forecast Period |
2025-2032 |
| Blood Banking Equipment Market Size 2024 |
USD 16347 Million |
| Blood Banking Equipment Market, CAGR |
4.8 % |
| Blood Banking Equipment Market Size 2032 |
USD 23786.3 Million |
Several key factors are driving the growth of the blood-banking equipment market. A rising number of surgical procedures and trauma cases, coupled with an increasing prevalence of chronic diseases like cancer and blood disorders, has boosted the need for blood and blood-derived products. The growing awareness of voluntary blood donation, improved healthcare infrastructure, and the implementation of strict quality and safety regulations in blood collection and storage also contribute to market expansion. Technological advancements—such as automation in blood processing, RFID tracking, pathogen reduction technologies, and integration of data analytics—are enhancing operational efficiency and product safety, further stimulating market growth. Increasing focus on precision medicine and personalized transfusion therapies, along with government-led initiatives for safe blood transfusion practices, are expected to add significant momentum to the market in the coming years. The demand for mobile blood collection units and remote access monitoring systems is also rising, particularly in underserved and rural areas. In addition, increased funding from both public health agencies and private donors is accelerating the adoption of next-generation blood-banking technologies.
North America dominates the blood-banking equipment market, supported by robust healthcare systems, government initiatives, and high awareness of blood donation safety. Key players such as Promat International, LivaNova PLC, MacoPharma SA, and Kawasumi Laboratories drive innovation and supply across the industry. Europe closely follows due to strict regulations and technology adoption. The Asia-Pacific region is growing fastest, fueled by rising healthcare investment, awareness, and demand in China and India. Expanding diagnostic chains, government campaigns, and international partnerships are boosting infrastructure. Latin America, the Middle East, and Africa are emerging, with gradual adoption supported by public and private investment, policy reforms, and training programs.
Access crucial information at unmatched prices!
Request your sample report today & start making informed decisions powered by Credence Research Inc.!
Download Sample
Market Insights:
- The Blood-banking equipment market reached USD 16,347 million in 2024 and is projected to hit USD 23,786.3 million by 2032, at a CAGR of 4.8%.
- Increasing surgical procedures, trauma cases, and chronic diseases are significantly boosting demand for blood and related equipment.
- Technological advancements such as automation, RFID tracking, and pathogen reduction are driving efficiency, accuracy, and safety in blood management.
- Strict regulations, quality standards, and safety protocols are pushing healthcare providers to invest in advanced blood-banking systems.
- High equipment and maintenance costs, along with limited technical expertise, remain key challenges in resource-constrained regions.
- North America leads with 39.2% market share, followed by Europe at 27.5% and Asia-Pacific at 23.1%, the latter showing the fastest growth.
- Public awareness campaigns, international collaborations, and the expansion of mobile and remote collection units are strengthening infrastructure and boosting adoption in emerging markets.
Market Drivers:
Rising Global Demand for Blood and Blood-Derived Products Drives Equipment Adoption
The Blood-banking equipment market is expanding due to the increasing need for safe and reliable blood supplies worldwide. A growing number of surgeries, trauma cases, and chronic diseases such as cancer, hemophilia, and blood disorders are fueling demand for blood components. Healthcare facilities are under pressure to maintain adequate inventories, which has elevated the importance of advanced equipment in collection, processing, and storage. The market benefits from a steady rise in demand for packed red blood cells, plasma, and platelets in both therapeutic and surgical applications. Blood shortages during public health emergencies have further underscored the need for efficient equipment solutions. This trend is especially pronounced in urban hospitals and regional transfusion centers with high patient volumes.
- For instance, Terumo BCT’s Trima Accel system was used to collect and process over 11 million blood component donations globally in 2023, according to the company’s annual performance report.
Technological Advancements Enhance Efficiency, Accuracy, and Safety in Blood Management
Automation and digital innovation are transforming how blood banks operate, contributing significantly to market growth. The Blood-banking equipment market is seeing rising adoption of automated blood mixers, centrifuges, pathogen reduction systems, and smart storage units. These technologies reduce human error, improve throughput, and ensure traceability across the supply chain. Integration of RFID tags, barcode systems, and inventory management software enhances traceability and minimizes wastage. It enables real-time monitoring of temperature, volume, and expiration dates, optimizing overall inventory performance. Advances in cold chain logistics and mobile blood collection devices are also helping reach remote and underserved populations.
- For instance, Haemonetics’ SafeTrace Tx software platform was deployed in 950 hospitals by the end of 2023, supporting over 2 million safe transfusion events with automated tracking, according to Haemonetics’ official product documentation.
Government Regulations and Blood Safety Protocols Increase Market Accountability
Stricter safety guidelines and regulatory frameworks are compelling healthcare providers to upgrade outdated systems. The Blood-banking equipment market is responding to national and international mandates on quality, contamination control, and donor-recipient safety. Governments and health organizations require compliance with Good Manufacturing Practices (GMP), ISO standards, and FDA regulations. These mandates are driving investment in sophisticated equipment capable of meeting evolving benchmarks. Donor screening technologies and leukoreduction filters are now standard in many developed markets. Institutions face both regulatory and reputational risks if they fail to meet safety standards.
Growth in Voluntary Donations and Public Health Initiatives Strengthens Supply Chain
Global awareness campaigns and public health efforts are increasing voluntary blood donations. It strengthens the supply chain and requires facilities to scale up operations using advanced blood-banking systems. The Blood-banking equipment market is benefiting from programs led by organizations such as the WHO and Red Cross, aimed at creating sustainable national blood systems. Emerging economies are investing in modern blood centers with standardized equipment and trained personnel. Community outreach programs and donor retention strategies also improve donor confidence and collection frequency. These developments create a need for scalable, durable, and intelligent equipment solutions.
Market Trends:
Integration of Digital Technologies and Automation is Streamlining Blood Bank Operations
The Blood-banking equipment market is witnessing a clear shift toward automation and digital integration to improve operational accuracy and traceability. Automated systems for blood collection, separation, and testing reduce manual intervention and minimize the risk of contamination or human error. Equipment with real-time data tracking, cloud-based inventory systems, and smart diagnostics is enabling faster decision-making and optimized resource utilization. RFID tagging and barcode scanning are becoming standard practices, ensuring efficient inventory management and reducing wastage. These advancements also support compliance with regulatory standards by maintaining detailed digital records. Laboratories and healthcare facilities are prioritizing systems that can integrate with hospital information systems (HIS) and laboratory information management systems (LIMS).
Personalized Medicine and Decentralized Blood Collection Are Expanding Equipment Requirements
The growing focus on personalized healthcare is influencing demand for specialized blood components and customized transfusion strategies. The Blood-banking equipment market is evolving to support this trend by offering equipment tailored for niche needs such as leukoreduction, irradiation, and component-specific storage. At the same time, decentralized and mobile blood collection units are gaining popularity to reach rural and remote areas, especially in low- and middle-income countries. These mobile units require compact, durable, and portable equipment that can operate under diverse environmental conditions. Investments in mobile healthcare infrastructure and emergency preparedness are creating new demand channels. The trend toward patient-specific blood management is also encouraging hospitals to invest in modular, flexible equipment systems that can adapt to evolving clinical needs.
- For instance, Terumo BCT launched the Trima Accel Automated Blood Collection System, which is now deployed in over 7,000 blood centers globally, as per company reports from 2024. The device enables real-time customization for leukoreduction and component separation, with each unit capable of processing up to 10 blood components per hour under varied conditions.
Market Challenges Analysis:
High Cost of Advanced Equipment and Maintenance Limits Access in Resource-Constrained Settings
The Blood-banking equipment market faces significant challenges due to the high cost of advanced systems and their associated maintenance requirements. Many healthcare facilities in low- and middle-income countries struggle to afford sophisticated equipment for blood collection, processing, and storage. High initial investment, regular calibration, and service support further add to the financial burden. Limited access to technical expertise and replacement parts can lead to equipment downtime and inefficiencies. These cost-related constraints hinder the modernization of blood banks and slow the adoption of automated technologies. Public hospitals and rural health centers often continue to rely on outdated equipment due to budgetary limitations.
Lack of Standardization and Skilled Workforce Affects Operational Efficiency
Disparities in regulatory frameworks and operational protocols across regions create inconsistencies in blood-bank practices. The Blood-banking equipment market must address the challenge of standardization to ensure uniform safety and quality. In many regions, a shortage of trained personnel limits the effective use of advanced equipment. Without proper training, staff may not fully utilize system capabilities or follow optimal operating procedures. This reduces equipment efficiency and increases the risk of errors in blood handling. Ongoing training and standardized guidelines are essential to improve system reliability and ensure safe transfusion practices across healthcare settings.
Market Opportunities:
Expansion of Healthcare Infrastructure in Emerging Markets Unlocks Growth Potential
The Blood-banking equipment market has strong opportunities in emerging economies undergoing rapid healthcare infrastructure development. Governments and private investors are expanding hospital networks, diagnostic centers, and emergency care facilities, which increases demand for modern blood-banking systems. Rising awareness about voluntary blood donation and improved access to healthcare services support wider adoption of collection and storage technologies. Countries in Asia, Latin America, and Africa are prioritizing the establishment of national blood programs and centralized transfusion services. This creates sustained demand for scalable and cost-effective equipment solutions. The growing presence of international aid organizations is also helping bridge resource gaps and promote modernization.
Rising Demand for Specialized Blood Components Creates Need for Advanced Equipment
Personalized therapies and targeted treatment approaches are driving demand for component-specific blood processing. The Blood-banking equipment market is well positioned to benefit from the increased use of plasma, platelets, and leukocyte-reduced products. Hospitals and specialty clinics are investing in devices that allow precise separation, pathogen inactivation, and storage under controlled conditions. Advanced systems that support extended shelf life and improved quality of blood products offer competitive advantages. The trend toward outpatient transfusion centers and home-based care also opens new avenues for compact and portable equipment. Continuous innovation in biotechnology and regenerative medicine will further expand the scope of application for next-generation blood-banking devices.
Market Segmentation Analysis:
By Blood Collection Devices
The Blood-banking equipment market includes blood collection monitors, collection bags, needles, and mobile collection units in this segment. These devices ensure safe and efficient donor blood collection, supporting accuracy, comfort, and traceability. Technological improvements enable greater precision and donor safety, while mobile units extend access in remote or underserved regions. Growing voluntary blood donation initiatives and expanded collection programs drive significant demand for these solutions.
- For example, Terumo BCT’s Trima Accel Automated Blood Collection System processes up to 2.2 liters of whole blood per donation, significantly increasing plasma and platelet yield per donor session.
By Processing Devices
Processing devices in the market cover centrifuges, blood separators, leukoreduction filters, and pathogen reduction systems. This segment is central to the separation and preparation of blood components, directly impacting product quality and transfusion safety. Automation, smart controls, and advanced filtration help optimize throughput and minimize human error. Hospitals and blood centers increasingly invest in these devices to meet growing clinical demands and improve operational efficiency.
- For instance, Terumo BCT’s automated centrifuge-based blood component separator, Reveos, can process up to 4 whole blood units in approximately 25 minutes with a single centrifuge cycle, enabling a throughput of up to 12 units per hour, which significantly enhances productivity for large-volume blood centers.
By Storage Devices
This segment includes blood refrigerators, plasma freezers, platelet incubators, and cryopreservation systems. It plays a crucial role in preserving the quality and safety of blood and its components over time. Advanced storage solutions now feature real-time temperature monitoring, inventory management, and automated alarms to prevent spoilage or wastage. Healthcare providers rely on these devices to ensure compliance with regulatory standards and guarantee availability for transfusion needs.
Segmentations:
By Blood Collection Devices
- Monitors
- Collection Bags
- Needles
- Mobile Collection Units
By Processing Devices
- Centrifuges
- Blood Separators
- Leukoreduction Filters
- Pathogen Reduction Systems
By Storage Devices
- Blood Refrigerators
- Plasma Freezers
- Platelet Incubators
- Cryopreservation Systems
By Region
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East & Africa
Regional Analysis:
North America and Europe
North America and Europe Lead with 39% and 27% Market Share Respectively
North America holds 39% of the global Blood-banking equipment market, driven by advanced healthcare infrastructure, strong regulatory oversight, and widespread adoption of automated technologies. The United States remains the largest contributor due to consistent investment in transfusion safety and blood processing innovation. Government-led programs and compliance with FDA regulations support sustained demand for high-end systems. Europe accounts for 27% of the market, with key countries like Germany, the UK, and France implementing EU blood safety directives and investing in modern blood bank equipment. Research institutions and public health systems in the region are driving demand for reliable and traceable technologies. It continues to benefit from coordinated healthcare policies and high donor participation rates.
Asia-Pacific
Asia-Pacific holds 23% of the Blood-banking equipment market and is growing rapidly due to increasing healthcare access, population growth, and national blood program expansion. Countries such as China, India, and Japan are scaling infrastructure to meet rising demand for blood and components across urban and rural areas. The region is witnessing strong public health investments and a surge in voluntary blood donations. Governments are promoting the adoption of automated systems through policy reforms and targeted funding. Local manufacturers and global players are expanding their presence through strategic partnerships and regional production. It is expected to maintain the highest CAGR through the forecast period, driven by medical needs and healthcare modernization.
Latin America, Middle East, and Africa
Latin America, the Middle East, and Africa collectively account for 10% of the global Blood-banking equipment market, reflecting growing efforts to upgrade healthcare systems and improve blood safety. Brazil, Mexico, the UAE, and South Africa are leading adoption through national blood bank modernization plans and international collaborations. These regions face challenges such as limited infrastructure and workforce shortages, yet they are progressing steadily. Donor awareness campaigns and investments in mobile collection units are increasing equipment deployment in underserved areas. Governments are aligning with global standards to ensure quality and safety in transfusion practices. It is gaining momentum through expanding public-private partnerships and donor support initiatives.
Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!
Key Player Analysis:
- Abbott Laboratories
- Bio-Rad Laboratories Inc.
- Thermo Fisher Scientific Inc.
- Immucor
- Cerus Corporation
- LivaNova PLC
- MacoPharma SA
- Kawasumi Laboratories
Competitive Analysis:
The Blood-banking equipment market is highly competitive, featuring a mix of established multinational corporations and specialized regional players. Leading companies such as Terumo Corporation, Abbott Laboratories, Cerus Corporation, LivaNova PLC and Company drive innovation through significant investments in research and development. The market is characterized by ongoing product launches, technological upgrades, and strategic partnerships to enhance portfolio breadth and geographic reach. Companies focus on automation, data integration, and compliance with global safety standards to gain a competitive edge. It experiences intense price competition, especially in emerging markets where cost efficiency and after-sales support influence purchasing decisions. Strong distribution networks and continuous customer support help leading firms maintain their market positions. The presence of new entrants and regional manufacturers is increasing, pushing incumbents to accelerate innovation and improve value-added services.
Recent Developments:
- In June 2025, Cerus Corporation reported positive Phase 3 clinical trial results for its INTERCEPT Red Blood Cell system in the U.S., demonstrating safety and efficacy in pathogen reduction.
- In May 2025, LivaNova completed its premarket approval submission to the U.S. Food and Drug Administration for the aura6000™, an implantable hypoglossal nerve stimulation system designed to treat moderate to severe obstructive sleep apnea.
- In January 2025Abbott announced its participation in the ADLM 2025 Live Event, scheduled for July 27–31 in Chicago, featuring live demonstrations, scientific sessions, and MED Talks on topics such as HIV diagnostics, diabetes, chronic kidney disease, and women’s health
Market Concentration and Characteristics:
The Blood-banking equipment market displays moderate to high market concentration, with a handful of global players accounting for a significant share of total revenue. It features a blend of multinational corporations and agile regional firms, each contributing to product innovation and technology adoption. The market is defined by rigorous regulatory standards, a strong emphasis on automation, and continuous upgrades in quality control systems. High entry barriers exist due to the need for compliance, advanced R&D, and established distribution networks. It demands strong technical expertise and ongoing training to ensure safe and efficient operations. Companies compete on technology, service reliability, and the ability to provide integrated solutions that meet evolving healthcare needs.
Report Coverage:
The research report offers an in-depth analysis based on Blood Collection Devices, Processing Devices, Storage Devices, Region. It details leading market players, providing an overview of their business, product offerings, investments, revenue streams, and key applications. Additionally, the report includes insights into the competitive environment, SWOT analysis, current market trends, as well as the primary drivers and constraints. Furthermore, it discusses various factors that have driven market expansion in recent years. The report also explores market dynamics, regulatory scenarios, and technological advancements that are shaping the industry. It assesses the impact of external factors and global economic changes on market growth. Lastly, it provides strategic recommendations for new entrants and established companies to navigate the complexities of the market.
Future Outlook:
- Healthcare organizations will adopt modular blood-banking systems that support flexible workflows and rapid scalability.
- It will integrate advanced analytics and cloud-based platforms to optimize inventory and enhance decision-making in real time.
- Manufacturers will invest in pathogen reduction technologies to improve safety and extend shelf life of blood components.
- The market will shift toward portable and compact equipment to support mobile collections and decentralized healthcare delivery.
- It will embrace artificial intelligence for predictive maintenance and enhanced quality control across equipment lifecycles.
- Vendors will develop interoperable systems to ensure seamless data exchange with hospital and laboratory information systems.
- The focus on precision transfusion will drive demand for devices capable of processing specific blood components like plasma and platelets.
- It will encourage public–private partnerships to fund and deploy modern blood-banking systems in underserved regions.
- Manufacturers will design cost-effective solutions tailored for emerging economies, combining reliability with local service support.
- It will promote standardized training programs to ensure consistent operation, compliance, and user proficiency worldwide.
